Recent Advances in Nanomaterial‐Mediated Cell Death for Cancer Therapy DOI

Min Luo,

Yuanmin Wang,

Fukun Zhao

et al.

Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 5, 2024

Abstract Nanomedicine has shown great anticancer potential by disrupting redox homeostasis and increasing the levels of oxidative stress, but therapeutic effect is limited factors including intrinsic self‐protection mechanism tumors. Cancer cell death can be induced exploration different mechanisms, such as apoptosis, pyroptosis, necroptosis, cuproptosis, ferroptosis. The merging nanotechnology with biomedicine provided tremendous opportunities to construct death‐based nanomedicine for innovative cancer therapy. Nanocarriers are not only used targeted delivery inducers, also components induce achieve efficient tumor treatment. This review focuses on seven modalities mediated nanomaterials, ferroptosis, cuprotosis, immunogenic death, autophagy. mechanisms these described in detail, well preparation nanomaterials that them they exert their effects. Finally, this work describes future development based current knowledge related nanomaterials.

Language: Английский

Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine DOI
Yanhong Su, Bing Liu, Binghan Wang

et al.

Small, Journal Year: 2024, Volume and Issue: 20(25)

Published: Jan. 14, 2024

Abstract Ferroptosis is a new form of regulated cell death featuring iron‐dependent lipid peroxides accumulation to kill tumor cells. A growing body evidence has shown the potential ferroptosis‐based cancer therapy in eradicating refractory malignancies that are resistant apoptosis‐based conventional therapies. In recent years, studies have reported number ferroptosis inducers can increase vulnerability cells by regulating ferroptosis‐related signaling pathways. Encouraged rapid development ferroptosis‐driven therapies, interdisciplinary fields combine ferroptosis, pharmaceutical chemistry, and nanotechnology focused. First, prerequisites metabolic pathways for briefly introduced. Then, detail emerging designed boost ferroptosis‐induced therapy, including metal complexes, metal‐based nanoparticles, metal‐free nanoparticles summarized. Subsequently, application synergistic strategies with apoptosis other emphasis on use both cuproptosis induce redox dysregulation intracellular bimetallic copper/iron metabolism disorders during treatment discussed. Finally, challenges associated clinical translation future directions potentiating therapies highlighted.

Language: Английский

Citations

19

Applications and Enhancement Strategies of ROS-based Non-invasive Therapies in Cancer Treatment DOI Creative Commons
Qiuyan Guo,

Yingnan Tang,

Shengmei Wang

et al.

Redox Biology, Journal Year: 2025, Volume and Issue: unknown, P. 103515 - 103515

Published: Jan. 1, 2025

Language: Английский

Citations

2

Unleashing the power of porphyrin photosensitizers: Illuminating breakthroughs in photodynamic therapy DOI
Alibasha Akbar, Syamantak Khan, Tanmay Chatterjee

et al.

Journal of Photochemistry and Photobiology B Biology, Journal Year: 2023, Volume and Issue: 248, P. 112796 - 112796

Published: Oct. 4, 2023

Language: Английский

Citations

40

Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy DOI Creative Commons

Afsana Sheikh,

Prashant Kesharwani, Waleed Hassan Almalki

et al.

Nano-Micro Letters, Journal Year: 2024, Volume and Issue: 16(1)

Published: May 2, 2024

As a new form of regulated cell death, ferroptosis has unraveled the unsolicited theory intrinsic apoptosis resistance by cancer cells. The molecular mechanism depends on induction oxidative stress through excessive reactive oxygen species accumulation and glutathione depletion to damage structural integrity Due their high loading tunability, nanocarriers can escort delivery ferro-therapeutics desired site enhanced permeation or retention effect active targeting. This review shed light necessity iron in growth fascinating features regulating cycle metastasis. Additionally, we discussed ferroptosis-mediated therapy using nanoplatforms chemical basis overcoming barriers therapy.

Language: Английский

Citations

9

Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges DOI Creative Commons
Yixiang Hu,

Ying Huang,

Lijuan Zong

et al.

Cell Death Discovery, Journal Year: 2024, Volume and Issue: 10(1)

Published: June 24, 2024

Abstract Pulmonary fibrosis (PF) is a chronic interstitial lung disorder characterized by abnormal myofibroblast activation, accumulation of extracellular matrix (ECM), and thickening fibrotic alveolar walls, resulting in deteriorated function. PF initiated dysregulated wound healing processes triggered factors such as excessive inflammation, oxidative stress, coronavirus disease (COVID-19). Despite advancements understanding the disease’s pathogenesis, effective preventive therapeutic interventions are currently lacking. Ferroptosis, an iron-dependent regulated cell death (RCD) mechanism involving lipid peroxidation glutathione (GSH) depletion, exhibits unique features distinct from other RCD forms (e.g., apoptosis, necrosis, pyroptosis). Imbalance between reactive oxygen species (ROS) production detoxification leads to ferroptosis, causing cellular dysfunction through peroxidation, protein modifications, DNA damage. Emerging evidence points crucial role ferroptosis progression, driving macrophage polarization, fibroblast proliferation, ECM deposition, ultimately contributing tissue scarring. This review provides comprehensive overview latest findings on involvement signaling mechanisms emphasizing potential novel anti-fibrotic approaches targeting for management.

Language: Английский

Citations

8

Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance DOI
Jing Cai, Xiaoding Xu, Phei Er Saw

et al.

Science China Life Sciences, Journal Year: 2023, Volume and Issue: 67(1), P. 19 - 40

Published: Sept. 15, 2023

Language: Английский

Citations

22

Intelligent Size‐Switchable Iron Carbide‐Based Nanocapsules with Cascade Delivery Capacity for Hyperthermia‐Enhanced Deep Tumor Ferroptosis DOI
Jingjing Wang, Zhi Fang, Chenyang Zhao

et al.

Advanced Materials, Journal Year: 2023, Volume and Issue: 36(9)

Published: Nov. 4, 2023

The ferroptosis pathway is recognized as an essential strategy for tumor treatment. However, killing cells in deep regions with agents still challenging because of distinct size requirements intratumoral accumulation and penetration. Herein, intelligent nanocapsules size-switchable capability that responds to acid/hyperthermia stimulation achieve are developed. These constructed using poly(lactic-co-glycolic) acid Pluronic F127 carrier materials, Au-Fe

Language: Английский

Citations

20

Ferroptosis as a promising therapeutic strategy for melanoma DOI Creative Commons
Na Ta, Xiaodong Jiang, Yongchun Zhang

et al.

Frontiers in Pharmacology, Journal Year: 2023, Volume and Issue: 14

Published: Sept. 19, 2023

Malignant melanoma (MM) is the most common and deadliest type of skin cancer associated with high mortality rates across all races ethnicities. Although present treatment options combined surgery provide short-term clinical benefit in patients early diagnosis non-metastatic MM significantly increases probability survival, no efficacious treatments are available for MM. The etiology pathogenesis complex. Acquired drug resistance a pool prognosis advanced-stage Thus, these require new therapeutic strategies to improve their response prognosis. Multiple studies have revealed that ferroptosis, non-apoptotic form regulated cell death (RCD) characterized by iron dependant lipid peroxidation, can prevent development Recent indicated targeting ferroptosis promising strategy This review article summarizes core mechanisms underlying cells its potential role as target We emphasize emerging types small molecules inducing pathways boosting antitumor activity BRAFi immunotherapy uncover beneficial effects treat also summarize application nanosensitizer-mediated unique dynamic ferroptosis-based nanodrug suggests pharmacological induction may be

Language: Английский

Citations

18

Ferroptosis inducers: A new frontier in cancer therapy DOI
Wenjing Ma,

Naiyuan Hu,

Wenqian Xu

et al.

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 146, P. 107331 - 107331

Published: April 2, 2024

Language: Английский

Citations

7

Advancements in the synthesis of carbon dots and their application in biomedicine DOI
Jia Xu,

Bing‐Bing Huang,

Chun-Mei Lai

et al.

Journal of Photochemistry and Photobiology B Biology, Journal Year: 2024, Volume and Issue: 255, P. 112920 - 112920

Published: April 21, 2024

Language: Английский

Citations

7